Drug Interactions and Side Effects Analysis of Thalomid and Dexamethasone and Nystatin and Protonix and Zometa and Plavix and Dapsone and Aranesp and Acyclovir and Benicar and Hydrochlorothiazide and Norvasc and Nitroglycerin and Warfarin Sodium and Avandia and Starlix and Lovastatin and Allopurinol
>>> Check drugs in a new way
| Report ID | Date of report | Patient age | Patient gender |
| 60045 | Feb, 17, 2006 | 69 | Male |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Thalomid | thalidomide |
Dexamethasone | dexamethasone |
Nystatin | nystatin |
Protonix | pantoprazole sodium |
Zometa | zoledronic acid |
Plavix | clopidogrel bisulfate |
Dapsone | dapsone |
Aranesp | darbepoetin alfa |
Acyclovir | acyclovir sodium |
Benicar | olmesartan medoxomil |
Hydrochlorothiazide | hydrochlorothiazide |
Norvasc | amlodipine besylate |
Nitroglycerin | nitroglycerin |
Warfarin Sodium | warfarin sodium |
Avandia | rosiglitazone maleate |
Starlix | nateglinide |
Lovastatin | lovastatin |
Allopurinol | allopurinol |
| Name |
Blood Creatinine Increased |
Cardiac Arrest |
Cardiac Failure Congestive |
Chest Pain |
Coronary Artery Disease |
Coronary Artery Surgery |
Dyspnoea |
Hypercoagulation |
Laboratory Test Abnormal |
Metabolic Acidosis |
Myocardial Infarction |
Ventricular Fibrillation |
Results from eHealthMe : 5 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Blood Creatinine Increased | 1 (20.00%) |
Cardiac Arrest | 3 (60.00%) |
Cardiac Failure Congestive | 4 (80.00%) |
Chest Pain | 1 (20.00%) |
Coronary Artery Disease | 1 (20.00%) |
Coronary Artery Surgery | 1 (20.00%) |
Dyspnoea | 1 (20.00%) |
Hypercoagulation | 2 (40.00%) |
Laboratory Test Abnormal | 1 (20.00%) |
Metabolic Acidosis | 2 (40.00%) |
Myocardial Infarction | 5 (100.00%) |
Ventricular Fibrillation | 2 (40.00%) |
Top 3 (total: 0. Click here to see more) co-used drugs - potential interacting drugs:
Death reported: 0
| Name | Count (% of total reports) |
Myocardial Infarction | 5 (100.00%) |
Renal Failure Acute | 4 (80.00%) |
Cardiac Failure Congestive | 4 (80.00%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
